Checkpoint Inhibitors and SBRT for MCRPC

Clinical trial NCT05655715 · COMPLETED

Trial details

NCT number: NCT05655715
Sponsor: Herlev and Gentofte Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer Metastatic Castrate Resistant Prostate Cancer Metastatic Castration-resistant Prostate Cancer Prostate Cancer Stage IV

Start date: 2019-11-25
Primary completion: 2024-08-30
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.